Oxidation of Arg-410 promotes the elimination of human serum albumin

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1764, Issue 4, 2006, Pages 743-749

  Iwao, Yasunori ^a   Anraku, Makoto ^a   Yamasaki, Keishi ^a   Kragh Hansen, Ulrich ^b   Kawai, Keiichi ^c   Maruyama, Toru ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b AARHUS UNIVERSITY   (Denmark)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Arg 410; Elimination; Human serum albumin; Liver clearance; Oxidation

Indexed keywords

ARGININE; CARBONYL DERIVATIVE; INDIUM 111; METAL ION; MUTANT PROTEIN; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; EVALUATION; HALF LIFE TIME; HUMAN; HYDROPHOBICITY; INCUBATION TIME; LABELING INDEX; LIVER CLEARANCE; MALE; MOLECULE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SPECTROSCOPY; TIME;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; HALF-LIFE; HUMANS; HYDROPHOBICITY; KETOPROFEN; LIVER; MALE; MICE; OXIDATION-REDUCTION; POINT MUTATION; PROTEIN CONFORMATION; SERUM ALBUMIN; WARFARIN;

ANIMALIA;

EID: 33646108139     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.01.011     Document Type: Article

References (43)

1. Peters Jr. T. All About Albumin: Biochemistry, Genetics, and Medical Applications (1996), Academic Press, San Diego
2. Mego J.L. Role of thiols, pH and cathepsin D in the lysosomal catabolism of serum albumin. Biochem. J. 218 (1984) 775-783
3. Anraku M., Kragh-Hansen U., Kawai K., Maruyama T., Yamasaki Y., Takakura Y., and Otagiri M. Validation of the chloramine-T induced oxidation of human serum albumin as a model for oxidative damage in vivo. Pharm. Res. 20 (2003) 684-692
4. Niedowicz D.M., and Daleke D.L. The role of oxidative stress in diabetic complications. Cell Biochem. Biophys. 43 (2005) 289-330
5. Vaziri N.D. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin. Nephrol. 24 (2004) 469-473
6. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radical Biol Med. 32 (2002) 797-803
7. Witko-Sarsat V., Friedlander M., Nguyen Khoa T., Capeillere-Blandin C., Nguyen A.T., Canteloup S., Dayer J.M., Jungers P., Drueke T., and Descamps-Latscha B. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J. Immunol. 161 (1998) 2524-2532
8. Davies K.J.A. Protein damage and degradation by oxygen radicals. J. Biol. Chem. 262 (1987) 9895-9901
9. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233 (1994) 346-363
10. Mera K., Anraku M., Kitamura K., Nakajou K., Maruyama T., and Otagiri M. The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst. Biochem. Biophys. Res. Commun. 334 (2005) 1322-1328
11. Ma S.F., Nishikawa M., Katsumi H., Yamashita F., and Hashida M. Cationic charge-dependent hepatic delivery of amidated serum albumin. J. Control. Release 102 (2005) 583-594
12. Yamasaki Y., Sumimoto K., Nishikawa M., Yamashita F., Yamaoka K., Hashida M., and Takakura Y. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors. J. Pharmacol. Exp. Ther. 301 (2002) 467-477
13. Sheffield W.P., Marques J.A., Bhakta V., and Smith I.J. Modulation of clearance of recombinant serum albumin by either glycosylation or truncation. Thromb. Res. 99 (2000) 613-621
14. Anraku M., Kitamura K., Shinohara A., Adachi M., Suenaga A., Maruyama T., Miyanaka K., Miyoshi T., Shiraishi N., Nonoguchi H., Otagiri M., and Tomita K. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int. 66 (2004) 841-848
15. Watanabe H., Yamasaki K., Kragh-Hansen U., Tanase S., Harada K., Suenaga A., and Otagiri M. In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharm. Res. 18 (2001) 1775-1781
16. Chen R.F. Removal of fatty acids from serum albumin by charcoal treatment. J. Biol. Chem. 242 (1967) 173-181
17. Meucci E., Mordente A., and Martorana G.E. Metal-catalyzed oxidation of human serum albumin: conformational and functional changes. J. Biol. Chem. 266 (1991) 4692-4699
18. Climent I., Tsai L., and Levine R.L. Derivatization of gamma-glutamyl semialdehyde residues in oxidized proteins by fluoresceinamine. Anal. Biochem. 182 (1989) 226-232
19. Hnatowich D.J., Latne W.W., and Childs R.L. The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Isot. 33 (1982) 327-332
20. 125I. Effect of labeling on distribution and excretion of radioactivity in rats. J. Pharm. Sci. 88 (1999) 577-585
21. Duncan J.R., and Welch M.J. Intracellular metabolism of indium 111-DTPA-labeled receptor targeted proteins. J. Nucl. Med. 34 (1993) 1728-1738
22. Yamaoka K., Tanigawara Y., Nakagawa T., and Uno T. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobio-dyn. 4 (1981) 879-885
23. Mukai T., Arano Y., Nishida K., Sasaki H., Saji H., and Nakamura J. In-vivo evaluation of indium-111-diethylenetri-aminepentaacetic acid labelling for determining the sites and rates of protein catabolism in mice. J. Pharm. Pharmacol. 51 (1999) 15-20
24. Pande P.G., Nellore R.V., and Bhagat H.R. Optimization and validation of analytical conditions for bovine serum albumin using capillary electrophoresis. Anal. Biochem. 204 (1992) 103-106
25. Anraku M., Yamasaki K., Maruyama T., Kragh-Hansen U., and Otagiri M. Effect of oxidative stress on the structure and function of human serum albumin. Pharm. Res. 18 (2001) 632-639
26. Sugio S., Kashima A., Mochizuki S., Noda M., and Kobayashi K. Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng. 12 (1999) 439-446
27. Nakajou K., Watanabe H., Kragh-Hansen U., Maruyama T., and Otagiri M. The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim. Biophys. Acta 1623 (2003) 88-97
28. Segal H.L., Rothstein D.M., and Winkler J.R. A correlation between turnover rates and lipophilic affinities of soluble rat liver proteins. Biochem. Biophys. Res. Commun. 73 (1976) 79-84
29. Bhattacharya A.A., Grüne T., and Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303 (2000) 721-732
30. Watanabe H., Kragh-Hansen U., Tanase S., Nakajou K., Mitarai M., Iwao Y., Maruyama T., and Otagiri M. Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem. J. 357 (2001) 269-274
31. Ahmed N., Dobler D., Dean M., and Thornalley P.J. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J. Biol. Chem. 280 (2005) 5724-5732
32. Smedsrød B., Melkko J., Araki N., Sano H., and Horiuchi S. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal, Kupffer and endothelial cells. Biochem. J. 322 (1997) 567-573
33. Matsumoto K., Sano H., Nagai R., Suzuki H., Kodama T., Yoshida M., Ueda S., Smedsrød B., and Horiuchi S. Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A. Biochem. J. 352 (2000) 233-240
34. Kodama T., Freeman M., Rohrer L., Zabrecky J., Matsudaira P., and Krieger M. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343 (1990) 531-535
35. Nagelkerke J.F., Barto K.P., and van Berkel T.J.C. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer and parenchymal cells. J. Biol. Chem. 258 (1983) 12221-12227
36. Malerod L., Juvet K., Gjoen T., and Berg T. The expression of scavenger receptor class B, type I (SR-BI) and caveolin-1 in parenchymal and nonparenchymal liver cells. Cell Tissue Res. 307 (2002) 173-180
37. Duryee M.J., Freeman T.L., Willis M.S., Hunter C.D., Hamilton B.C., Suzuki H., Tuma D.J., Klassen L.W., and Thiele G.M. Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol. Pharmacol. 68 (2005) 1423-1430
38. Adachi H., Tsujimoto M., Arai H., and Inoue K. Expression cloning of a novel scavenger receptor from human endothelial cells. J. Biol. Chem. 272 (1997) 31217-31220
39. Hansen B., Longati P., Elvevold K., Nedredal G.I., Schledzewski K., Olsen R., Falkowski M., Kzhyshkowska J., Carlsson F., Johansson S., Smedsrød B., Goerdt S., Johansson S., and McCourt P. Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding. Exp. Cell Res. 303 (2005) 160-173
40. Tamura Y., Adachi H., Osuga J., Ohashi K., Yahagi N., Sekiya M., Okazaki H., Tomita S., Iizuka Y., Shimano H., Nagai R., Kimura S., Tsujimoto M., and Ishibashi S. FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J. Biol. Chem. 278 (2003) 12613-12617
41. Schnitzerand J.E., and Bravo J. High affinity binding, endocytosis, and degradation of conformationally modified albumins: potential role of gp30 and gp18 as novel scavenger receptors. J. Biol. Chem. 268 (1993) 7562-7570
42. Bito R., Hino S., Baba A., Tanaka M., Watabe H., and Kawabata H. The degradation of oxidative stress-induced denatured albumin in rat liver endothelial cells. Am. J. Physiol.: Cell Physiol. 289 (2005) C531-C542
43. Nakajou K., Horiuchi S., Sakai M., Hirata K., Tanaka M., Takeya M., Kai T., and Otagiri M. CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells. J. Biochem. (Tokyo) 137 (2005) 607-616